Wellington Management Group LLP Theseus Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.28 - $11.82 $306,204 - $497,161	42,061 Added 37.69%	153,673 $1.43 Million
Q1 2023 May 12, 2023	BUY	$5.21 - $14.05 $581,498 - $1.57 Million	111,612 New	111,612 $991,000
Q3 2022 Nov 14, 2022	BUY	$5.7 - $8.68 $640,742 - $975,727	112,411 Added 186.87%	172,566 $1 Million
Q2 2022 Aug 15, 2022	SELL	$5.04 - $14.05 $1.18 Million - $3.28 Million	-233,432 Reduced 79.51%	60,155 $332,000
Q1 2022 May 16, 2022	SELL	$8.75 - $14.51 $2.9 Million - $4.81 Million	-331,233 Reduced 53.01%	293,587 $3.39 Million
Q4 2021 Feb 11, 2022	BUY	$8.98 - $20.09 $5.61 Million - $12.6 Million	624,820 New	624,820 $7.92 Million

1.03M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.